Number of eligible clients: CDEC mentioned the uncertainty in the amount of patients with moderately severe to severe hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical gurus consulted by CADTH indicated that some people who will be labeled as obtaining gentle or average ailment may have a severe bleeding https://hemgenix83824.tkzblog.com/35543288/the-definitive-guide-to-hemgenix